Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-06-18FDA Approved: PULMICORT RESPULES — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Pulmicort Respules (budesonide) submitted by AstraZeneca Pharmaceuticals LP. The action pertains…
-
CLINICAL_TRIALS research · 2007-06-12Clinical Trial Update: Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide [NA]
A clinical trial investigating grass allergen immunotherapy and bronchial inflammation in asthma and allergic rhinitis. The status of the st…
-
FDA approval · 2007-05-22FDA Approved: IPRATROPIUM BROMIDE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application from Apotex Corp. for ipratropium bromide.
-
FDA approval · 2007-05-11FDA Approved: FORMOTEROL FUMARATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for Formoterol Fumarate Dihydrate (FORMOTEROL FUMARATE) by Mylan Pharmaceuticals Inc., a long-acting b…
-
CLINICAL_TRIALS research · 2007-05-02Clinical Trial Update: Evaluation of Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary [NA]
A completed clinical trial comparing traditional paper symptom diaries with the VOCEL Mobile Diary for asthma symptom tracking.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2007-04-13FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC. The approval updates the drug's labelin…
-
FDA approval · 2007-04-13FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2007-04-11Clinical Trial Update: Body Plethysmograph Measurements Before and After Methacholine Challenge in Early Childhood
A completed clinical trial examined lung function in early childhood by body plethysmography before and after a methacholine challenge in ch…
-
CLINICAL_TRIALS trial_result · 2007-04-06Clinical Trial Update: ParentLink: Better and Safer Emergency Care for Children
The ParentLink trial, sponsored by Boston Children's Hospital, evaluating safer emergency care for children, has completed. It enrolled pedi…
-
FDA approval · 2007-03-29FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Chartwell RX, LLC.)
The FDA approved a supplemental application for albuterol sulfate from Chartwell RX, LLC., updating an existing generic product.
-
FDA approval · 2007-03-28FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Nephron Pharmaceuticals Corporation)
FDA approved a supplemental application for albuterol sulfate from Nephron Pharmaceuticals Corporation under an abbreviated new drug applica…
-
CLINICAL_TRIALS research · 2007-03-21Clinical Trial Update: Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood
A clinical trial update examining how allergen inhalation influences adenosine receptor expression in sputum and peripheral blood in individ…
-
CLINICAL_TRIALS trial_result · 2007-03-06Clinical Trial Update: Exercise Challenge Test in 3-6 Years Old Asthmatic Children
A completed clinical trial evaluating an exercise challenge test in children aged 3-6 with asthma has been reported.
-
CLINICAL_TRIALS research · 2007-03-01Clinical Trial Update: Evaluation of Spirometry Expert Support in General Practice [NA]
Clinical trial update evaluating spirometry expert support in general practice; status appears UNKNOWN with no posted results.
-
FDA approval · 2007-02-23FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2007-02-23FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) filed by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2007-02-21Clinical Trial Update: Housing, Insulation and Health Study [NA]
This completed clinical trial conducted by the University of Otago evaluated the impact of housing insulation and related environmental fact…
-
FDA approval · 2007-02-16FDA Approved: PULMICORT FLEXHALER — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for Pulmicort Flexhaler (budesonide) submitted by H2-Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2007-02-16Clinical Trial Update: Control of Asthma Patients Symptomatic on Inhaled Corticosteroids [Phase 2]
A Phase 2 trial evaluating control of asthma symptoms in patients on inhaled corticosteroids has completed. The sponsor is Inflazyme Pharmac…
-
FDA approval · 2006-12-28FDA Approved: EPINEPHRINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for EPINEPHRINE from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2006-12-14Clinical Trial Update: Patient Research In Self-Management of Asthma (PRISMA) [Phase 4]
Phase 4 trial PRISMA on patient self-management in asthma has completed.
-
CLINICAL_TRIALS research · 2006-12-12Clinical Trial Update: Bikram Yoga and Asthma [NA]
Clinical trial update on Bikram Yoga as a treatment for asthma; sponsored by Hadassah Medical Organization; current status is UNKNOWN.
-
FDA approval · 2006-12-08FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2006-12-05Clinical Trial Update: AKL 1 Asthma Study [Phase 2]
The AKL 1 asthma study (Phase 2) sponsored by the University of Aberdeen has completed.
-
CLINICAL_TRIALS trial_result · 2006-12-04Clinical Trial Update: FLAME: Airway Inflammation Monitoring in Asthma and Cystic Fibrosis
The FLAME trial assessing airway inflammation monitoring in asthma and cystic fibrosis has completed. The update provides status information…